Dynorphin B Creates a Self-Amplifying Loop in Diseased Heart Cells | Research

The takeaway

Dynorphin B stimulates its own gene expression in cardiac myocytes through an autocrine feedback loop, which is dramatically amplified in cardiomyopathic hearts.

Self-amplifying opioid loop
Dynorphin B stimulates its own gene expression in heart cells, creating a dose-dependent autocrine feedback loop amplified in disease

What the researchers found

Dynorphin B induces dose-dependent autocrine stimulation of its own gene expression in cardiac myocytes, creating a self-amplifying loop that is exaggerated in cardiomyopathy.

Why it matters

An autocrine opioid peptide amplification loop in the heart could represent a therapeutic target for treating cardiomyopathy by breaking the self-reinforcing cycle.

How the study worked

In vitro study using normal and cardiomyopathic hamster cardiac myocytes. Exogenous dynorphin B was added and prodynorphin mRNA levels and gene transcription were measured.

What this study cannot tell us

In vitro hamster cardiomyocyte study. The specific cardiomyopathy model (BIO 14.6) may not represent all human cardiomyopathies.

How to read the evidence

Moderate in vitro evidence from a hereditary cardiomyopathy model with clear dose-dependent autocrine effects.

When this study was published

Published in 1997, revealing a novel pathological mechanism of cardiac opioid peptide signaling.

The bigger picture

This finding revealed a novel pathological mechanism where opioid peptides contribute to heart disease progression through self-amplifying feedback, offering a potential drug target.

Questions still open

Could blocking the dynorphin autocrine loop slow cardiomyopathy progression?
Is this autocrine mechanism present in human cardiomyopathy?

Common questions

What is an autocrine loop?

Autocrine signaling is when a cell produces a substance that then acts back on the same cell to stimulate more production of that substance. It's a self-amplifying cycle that can spiral out of control in disease.

Why does this matter for heart disease?

In cardiomyopathy, dynorphin B production increases dramatically. This study shows the peptide stimulates its own further production, creating a vicious cycle. Breaking this cycle could be a new way to treat the disease.

Read the original research

Opioid peptide gene expression in the primary hereditary cardiomyopathy of the Syrian hamster. III. Autocrine stimulation of prodynorphin gene expression by dynorphin B.

The Journal of biological chemistry, 272(10), 6699-705

View on PubMed ↗

Citation

Ventura, C; Pintus, G. (1997). Opioid peptide gene expression in the primary hereditary cardiomyopathy of the Syrian hamster. III. Autocrine stimulation of prodynorphin gene expression by dynorphin B.. The Journal of biological chemistry, 272(10), 6699-705.